Kestra Medical Technologies (KMTS) Operating Expenses (2024 - 2026)

Kestra Medical Technologies (KMTS) has 3 years of Operating Expenses data on file, last reported at $55.0 million in Q2 2026.

• On a quarterly basis, Operating Expenses fell 1.47% year-over-year to $55.0 million in Q2 2026; TTM through Apr 2026 was $183.6 million, a 40.6% increase from a year earlier, with the FY2026 full-year figure at $183.6 million, up 40.6% from the prior year.
• Operating Expenses for Q2 2026 stood at $55.0 million, up from $47.7 million in the prior quarter.
• Over the last five years, Operating Expenses for KMTS reached as high as $55.8 million in Q2 2025 and fell as low as $20.8 million in Q1 2024.
• Historically, Operating Expenses has averaged $35.7 million across 3 years, with a median of $32.4 million in 2025.
• Across the five-year window, Operating Expenses jumped 156.81% in 2025 and decreased 1.47% in 2026, its largest moves.
• Year by year, Operating Expenses stood at $25.0 million in 2024, then surged by 72.97% to $43.2 million in 2025, then rose by 27.44% to $55.0 million in 2026.
• Per Business Quant data, the three most recent Operating Expenses figures were $55.0 million in Q2 2026, $47.7 million in Q1 2026, and $43.2 million in Q4 2025.